Summary
EU healthcare procurement is one of the most regulated and technically complex procurement sectors, covering medical devices, pharmaceuticals, diagnostics, healthcare IT, patient services, and hospital facility management. The sector is worth over €140 billion annually in public spending across the EU, with procurement handled by a combination of individual hospital authorities, regional health agencies, and centralised national purchasing bodies. Understanding the regulatory environment, centralised purchasing frameworks, and technical qualification requirements is essential for healthcare suppliers targeting EU public contracts in 2026.
The EU Healthcare Procurement Landscape
Healthcare is the EU's largest service sector, employing over 17 million people and accounting for approximately 10% of GDP in most member states. Public expenditure on health — through national health services, social insurance systems, and regional health authorities — is the primary driver of healthcare procurement.
The COVID-19 pandemic fundamentally changed EU healthcare procurement in several ways: it accelerated centralisation through bodies like the European Health Emergency preparedness and Response Authority (HERA), demonstrated the vulnerability of single-source supply chains, and drove massive investment in diagnostic equipment, PPE strategic reserves, and pandemic preparedness systems.
Key CPV Codes for Healthcare Procurement
- 33000000 — Medical equipment, pharmaceuticals and personal care products (top-level)
- 33100000 — Medical devices and equipment
- 33110000 — Imaging equipment (MRI, X-ray, CT scanners, ultrasound)
- 33140000 — Medical consumables (surgical instruments, disposables)
- 33150000 — Radiotherapy, mechanotherapy and electrotherapy equipment
- 33170000 — Anaesthesia and resuscitation equipment
- 33600000 — Pharmaceuticals
- 33620000 — Therapeutic products
- 85000000 — Health and social work services
- 85100000 — Health services
- 85110000 — Hospital and related services
- 72222000 — Health information systems (health IT)
Regulatory Compliance as a Qualification Requirement
Healthcare procurement is unique in that regulatory compliance is a prerequisite to participation, not merely a qualification criterion. Suppliers of medical devices must demonstrate compliance with the EU Medical Device Regulation (MDR — Regulation 2017/745) and In Vitro Diagnostic Regulation (IVDR — Regulation 2017/746), which replaced the previous MDD and IVDD directives. CE marking under MDR/IVDR is mandatory for medical device procurement.
Key compliance documentation typically required in healthcare tenders:
- CE Certificate and EU Declaration of Conformity for each device offered
- Notified Body involvement documentation (for Class IIa, IIb, and III devices)
- Post-market surveillance reports where requested
- ISO 13485 quality management system certification (medical devices)
- GMP certificates for pharmaceuticals
- Clinical evaluation reports for novel or complex devices
Centralised Purchasing Bodies in Healthcare
Healthcare is one of the most centralised procurement sectors in the EU. Rather than each hospital running its own tenders, many EU countries have established regional or national healthcare purchasing bodies that aggregate demand and run framework agreements covering hundreds of hospitals simultaneously. Getting onto these frameworks is often more valuable than winning individual hospital contracts — a single framework agreement can generate call-off contracts from dozens of hospitals over 4 years.
Key national CPBs by country:
- Italy — CONSIP: Italy's national central purchasing body manages approximately €8 billion in annual healthcare spend. Regional CPBs (INTERCENT-ER for Emilia-Romagna, ARCA for Lombardy) run parallel frameworks for their regions.
- France — UGAP Santé and RESAH: RESAH is specifically dedicated to healthcare procurement coordination across French hospital groups; UGAP Santé covers medical consumables and devices for the broader public health sector.
- Spain — INGESA and CCAA bodies: National and autonomous community health agencies run major frameworks for medical equipment and pharmaceuticals.
- Denmark — SKI (Statens og Kommunernes Indkøbsservice): Central purchasing for hospitals and municipalities.
- Czech Republic / Slovak Republic — ZSS/JOINTPRO: An emerging joint procurement model for medical countermeasures and pharmaceutical supply.
At EU level, the EU Joint Procurement Agreement (established under Decision 1082/2013/EU) allows up to 37 countries to participate in joint procurement coordinated by the European Commission. Originally used for vaccines and antivirals during the COVID-19 response, its scope is expanding to broader medical products and strategic health reserves. Suppliers targeting EU-level healthcare procurement should monitor HERA (Health Emergency preparedness and Response Authority) call-off notices published on TED.
Health IT: A Growing Opportunity
The EU's health data strategy — particularly the European Health Data Space (EHDS) Regulation, approved in 2024 — is driving major investment in health information systems, interoperability infrastructure, and electronic health records. Suppliers of health IT systems need to demonstrate compliance with FHIR (Fast Healthcare Interoperability Resources) standards and the EHDS data governance framework to compete effectively for public health IT contracts.
Life Cycle Costing in Healthcare Evaluation
Healthcare contracting authorities are increasingly using Life Cycle Costing (LCC) methodologies to evaluate medical equipment procurement. Rather than comparing purchase price alone, LCC includes installation, training, maintenance, consumables, and end-of-life disposal costs over the equipment's operational life — typically 7–15 years for imaging equipment. Suppliers with low purchase prices but high maintenance costs may lose to competitors with stronger LCC profiles. Prepare total cost of ownership models as standard for imaging, laboratory, and high-value medical equipment bids.